Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR (DISCORDANCE TAVR)
Completed
Conditions studied: Aortic Stenosis, Aortic Valve Stenosis
In brief
The DISCORDANCE TAVR study will determine the discordance between echocardiography-derived and invasive transaortic gradients, as determined by a consistent and reproducible technique (Standardized Invasive Hemodynamics) post-TAVR.
Key facts
- Study ID
- NCT04827238
- Run by
- University of British Columbia
- People needed
- 49
- Starts
- 2021-08-30
- Expected to finish
- 2025-06-20
- Last updated by the study team
- 2025-07-24
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Echocardiographic transaortic mean gradient ≥ 20mmHg OR VARC-3 criteria for ≥ moderate hemodynamic valve deterioration post TAVR on any TTE > 1 month post-TAVR
- Consensus by the Heart Team that the patient is suitable for Standardized Invasive Hemodynamics (SIH).
You may not qualify if…
- CT demonstrating leaflet thrombosis or hypoattenuated leaflet thickening (HALT)
Where it is running
- PIMA Heart Centre — Tucson, Arizona, United States
- Tenet Health — Boca Raton, Florida, United States
- eCommunity — Indianapolis, Indiana, United States
- Community Hospital — Munster, Indiana, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- William Beaumont Hospital — Southfield, Michigan, United States
- Vancouver General Hospital — Vancouver, British Columbia, Canada
- St. Paul's Hospital — Vancouver, British Columbia, Canada
- McMaster University — Hamilton, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.